⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hypophosphorous Acid SCHEMBL248597 | 0.58 | — | — | |
| Hypophosphorous Acid SCHEMBL31744127 | 0.58 | — | — | |
| Hypophosphorous Acid SCHEMBL6030539 | 0.58 | — | — | |
| SCHEMBL55855 | 0.55 | — | — | |
| SCHEMBL10782302 | 0.50 | — | — | |
| SCHEMBL641238 | 0.50 | — | — | |
| SCHEMBL7784434 | 0.50 | — | — | |
| Hypophosphorous Acid SCHEMBL11460 | 0.50 | — | — | |
| SCHEMBL3329117 | 0.50 | — | — | |
| SCHEMBL415960 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106631983-A | Toluylene-unit-based dendritic compound and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2017-05-10 | — | — | CN | claimed |
| US-7517900-B2 | Pyrazole derivatives as cannabinoid receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-04-14 | — | — | US | claimed |
| EP-1670460-A4 | PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1653962-A4 | PYRAZINE MODULATORS OF CANNABINOID RECEPTORS | BRISTOL MYERS SQUIBB CO (US) | 2008-06-11 | — | — | EP | claimed |
| EP-1644335-A4 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2008-06-04 | — | — | EP | claimed |
| EP-1644370-A4 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2008-06-04 | — | — | EP | claimed |
| JP-2007514770-A | — | — | 2007-06-07 | — | — | JP | claimed |
| EP-1697371-B1 | AZABICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2007-04-25 | — | — | EP | claimed |
| EP-1697370-B1 | AZABICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2007-04-25 | — | — | EP | claimed |
| EP-1697370-A1 | AZABICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS | Bristol-Myers Squibb Company (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005016286-A2 | PYRAZINE MODULATORS OF CANNABINOID RECEPTORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-02-24 | — | — | WO | claimed |
| WO-2005007111-A2 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-01-27 | — | — | WO | claimed |
| WO-2005007628-A1 | TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009870-A1 | Tetrahydroquinoline derivatives as cannabinoid receptor modulators | BRISTOL-MYERS SQUIBB COMPANY | 2005-01-13 | — | — | US | claimed |
| US-6562783-B2 | Therapy for Alzheimer's disease | NEUROLOGIC, INC. | 2003-05-13 | — | — | US | claimed |
| US-20030078240-A1 | Phosphinylmethyl and phosphorylmethyl succinic and glutaric acid analogs as beta-secretase inhibitors | NEUROLOGIC, INC. | 2003-04-24 | — | — | US | claimed |
| US-20020187928-A1 | Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors | NEUROLOGIC, INC. | 2002-12-12 | — | — | US | claimed |
| WO-2002096897-A1 | PHOSPHINYLMETHYL AND PHOSPHORYLMETHYL SUCCINIC AND GLUTARIC ACID ANALOGS AS β-SECRETASE INHIBITORS | NEUROLOGIC, INC. (US) | 2002-12-05 | — | — | WO | claimed |
| EP-0068378-B1 | NOVEL IMIDAZO(1,2-A)PYRIDINES AND PYRAZINES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1986-03-05 | — | — | EP | claimed |
| EP-0068378-A1 | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1983-01-05 | — | — | EP | claimed |